MANNKIND CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.35 USD | -0.68% |
|
+4.02% | +20.88% |
Chart calendar MannKind Corporation
d55819c4c84bc311568d28bc8.OLt0DGajuOqEUMWAhBkeHO7bCgs8jlQccVd_4xoXbog.CfYmYjbN3KPAHvXS7mN6btmfen5V7GIsBS4n0nhZMdhK1xI0HuTV0tI0lA~80324764ad9eec0156476ab28b9af22a
Upcoming events on MannKind Corporation
Past events on MannKind Corporation
| 13/03/2024 13:20 | Oppenheimer Healthcare MedTech & Services Conference |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 08/03/2024 16:15 | Advanced Technologies and Treatments for Diabetes International Conference |
| 27/02/2024 22:00 | Q4 2023 Earnings Call |
| 27/02/2024 21:00 | Q4 2023 Earnings Release |
| 11/01/2024 19:15 | JPMorgan Healthcare Conference |
| 03/01/2024 14:00 | Business Update Call |
| 07/11/2023 22:00 | Q3 2023 Earnings Call |
| 07/11/2023 21:00 | Q3 2023 Earnings Release |
| 27/09/2023 16:30 | Cantor Global Healthcare Conference |
| 13/09/2023 13:10 | Morgan Stanley Global Healthcare Conference |
| 11/09/2023 13:30 | H.C. Wainwright Global Investment Conference |
| 07/08/2023 | Wedbush PacGrow Healthcare Conference |
| 07/08/2023 22:00 | Q2 2023 Earnings Call |
| 07/08/2023 21:00 | Q2 2023 Earnings Release |
| 25/05/2023 15:00 | Annual General Meeting |
| 16/05/2023 19:05 | RBC Global Healthcare Conference |
| 09/05/2023 22:00 | Q1 2023 Earnings Call |
| 09/05/2023 21:00 | Q1 2023 Earnings Release |
| 14/03/2023 18:00 | Oppenheimer Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 63,0 62,1 1.56% | 65,1 62,9 3.61% | 75,4 80,0 -5.71% | 99,8 99,6 0.18% | 199 194 2.75% | 260 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -44,6 -43,3 -3.06% | -34,7 -31,2 -11.15% | -47,0 -36,3 -29.36% | -64,1 -58,5 -9.55% | 8,68 7,65 13.37% | 64,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,9 -51,7 -0.39% | -57,5 -40,4 -42.23% | -80,9 -72,0 -12.32% | -87,4 -79,8 -9.53% | -10,4 -7,96 -30.43% | 43,0 |
|
Net income Million USD | Released Forecast Spread | -51,9 -51,7 -0.39% | -57,2 -40,2 -42.27% | -80,9 -70,7 -14.45% | -87,4 -81,4 -7.37% | -11,9 -9,53 -25.27% | 38,8 |
|
EPS USD | Released Forecast Spread | -0,27 -0,26 -2.27% | -0,26 -0,18 -44.44% | -0,32 -0,28 -13.27% | -0,34 -0,32 -5.7% | -0,04 -0,05 23.08% | 0,13 |
| Announcement Date | 25/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,5 17,1 -26.71% | 12,0 10,6 13.28% | 18,9 15,6 20.95% | 32,8 25,0 31.32% | 36,1 35,5 1.53% | 40,6 37,4 8.63% | 48,6 42,9 13.18% | 51,3 50,7 1.04% | 58,5 53,1 10.03% | 60,5 | 63,6 | 66,4 | 69,4 |
|
EBIT Million USD | Released Forecast Spread | -24,0 -13,7 -74.63% | -21,3 -19,4 -9.81% | -20,5 -18,4 -11.14% | -9,61 -13,4 28.41% | -12,8 -7,63 -67.69% | -6,00 -8,93 32.87% | 1,72 -6,49 126.52% | 5,10 1,55 228.54% | 7,86 5,66 38.73% | 13,9 | 15,2 | 16,7 | 18,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,1 -19,2 -46.11% | -26,0 -23,3 -11.37% | -29,0 -23,0 -26.38% | -14,4 -17,8 19.12% | -17,9 -11,6 -54.9% | -9,80 -13,5 27.51% | -5,27 -12,7 58.51% | 1,72 -4,55 137.81% | 2,96 2,93 0.96% | 8,80 | 9,78 | 11,6 | 12,9 |
|
Net income Million USD | Released Forecast Spread | -28,1 -17,9 -56.51% | -26,0 -24,1 -8.05% | -29,0 -23,0 -25.92% | -14,4 -21,0 31.19% | -17,9 -13,0 -38.18% | -9,80 -13,4 26.85% | -5,27 -11,7 54.97% | 1,72 -4,51 138.16% | 1,40 1,78 -21.21% | 7,75 | 8,56 | 10,2 | 12,3 |
|
EPS USD | Released Forecast Spread | -0,11 -0,07 -51.72% | -0,10 -0,09 -7.15% | -0,11 -0,09 -18.92% | -0,06 -0,08 28% | -0,07 -0,05 -35.48% | -0,04 -0,05 20% | -0,02 -0,04 52.94% | 0,01 -0,02 154.56% | 0,00 0,00 29.13% | 0,03 | 0,03 | 0,03 | 0,04 |
| Announcement Date | 24/02/22 | 05/05/22 | 09/08/22 | 08/11/22 | 23/02/23 | 09/05/23 | 07/08/23 | 07/11/23 | 27/02/24 | - | - | - | - |
More events
Past sector events for MannKind Corporation
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MNKD Stock
- Calendar MannKind Corporation
